Rare diseases
Investigational molecules
Locations
128 Rue La Boetie, 75008 Paris, France
Corteria Pharmaceuticals focuses on chronic heart failure and worsening heart failure, with research activity centered on symptoms, fluid balance, and cardiac structure in patients with advanced cardiovascular disease.
The sponsor’s heart failure portfolio includes work in both symptomatic deterioration and broader chronic disease management, reflecting a strong therapeutic interest in cardiac remodeling and congestion-related outcomes.
Corteria Pharmaceuticals runs clinical trials in conditions such as Cardiac failure, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
